ArticleInternational journal of surgery case reports2026
Axillary metastasis in non-specific molecular profile of endometrial carcinoma: a case report and literature review.
Article in International journal of surgery case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Axillary metastasis in endometrial cancer is a rare entity. We present a case of axillary metastasis from high-grade endometrial carcinoma with a non-specific molecular protein classification. Case presentation: A 63-year-old woman with postmenopausal bleeding underwent a laparotomy for complete surgical staging and continued with adjuvant chemoradiation for stage IV high-grade endometrial carcinoma. Molecular profiling was performed and classified as non-specific molecular profile (NSMP). After completion of primary treatment, 10 months later, the patient developed a left axillary lump, which was confirmed on tumor resection specimen to be metastatic endometrial carcinoma. The patient then received another six cycles of chemotherapy and remains under surveillance with no evidence of disease after 2 years. Discussion: There are several pathways for metastasis to axillary nodes in endometrial cancer. The most probable is hematogenous spread. The NSMP group has an intermediate prognosis, with a tendency toward distant metastasis. Treatment options can vary from surgery with chemo- and/or radiotherapy to systemic therapy alone. Conclusion: Axillary metastasis in endometrial carcinoma is a rare finding, either as a primary event or in a recurrent setting. The NSMP molecular profile may be associated with distant metastasis, although the mechanism remains unknown. We suggest aggressive locoregional management, including surgery with chemo- and/or radiation therapy, which may be considered in similar cases with favorable outcomes.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.